Evaluating the efficacy of ursodeoxycholic acid plus methotrexate vs methotrexate alone in the treatment of moderate to severe plaque-type psoriasis: A randomized clinical trial

Dermatol Ther. 2020 Jul;33(4):e13455. doi: 10.1111/dth.13455. Epub 2020 May 12.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Immunosuppressive Agents
  • Methotrexate* / adverse effects
  • Psoriasis* / diagnosis
  • Psoriasis* / drug therapy
  • Severity of Illness Index
  • Treatment Outcome
  • Ursodeoxycholic Acid / therapeutic use

Substances

  • Immunosuppressive Agents
  • Ursodeoxycholic Acid
  • Methotrexate